Filing Details

Accession Number:
0000912282-24-000789
Form Type:
3
Zero Holdings:
No
Publication Time:
2024-11-12 19:11:48
Reporting Period:
2024-11-12
Accepted Time:
2024-11-12 19:11:48
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1655923 Alpha Cognition Inc. ACOG Biological Products, (No Disgnostic Substances) (2836) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
2028687 Powell Leonard Mertz C/O Alpha Cognition Inc.
1200 - 750 West Pender Street
Vancouver A1 V6C 2T8
No No No No
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Shares 138,495 Direct
Common Shares 85,030 Indirect by The Len Mertz Trust
Reported Derivative Holdings
Sec. Name Sec. Type Price Date Expiration Date Amount Remaning Holdings Nature of Ownership
Common Shares Common Share Options $5.21 2023-01-18 2031-12-20 12,000 0 Direct
Common Shares Common Share Options $5.21 2023-01-18 2032-05-31 4,000 0 Direct
Common Shares Common Share Options $4.12 2023-06-08 2033-06-08 20,000 0 Direct
Common Shares Class B Preferred Series A Shares $0.00 60,015 0 Direct
Expiration Date Amount Remaning Holdings Nature of Ownership
2031-12-20 12,000 0 Direct
2032-05-31 4,000 0 Direct
2033-06-08 20,000 0 Direct
60,015 0 Direct
Footnotes
  1. Options are fully vested.
  2. Converted from Canadian exercise price of C$7.00 at C$1.3439=USD$1.00.
  3. 12.5% vested on June 8, 2023, and the remaining 87.5% vests in equal monthly installments until January 30, 2026.
  4. Converted from Canadian exercise price of C$5.50 at C$1.3358=USD$1.00.
  5. The Class B Preferred Series A Shares are convertible at any time, at the holder's election, on a one-for-one basis, and will convert automatically upon certain events as described in the Issuer's Form S-1 registration statement. The Class B Preferred Series A Shares do not expire.